CBS & BRC joint Seminar Jeremy Hall- Investigating the impact of schizophrenia risk genes on learning and plasticity
We are pleased to invite you to this joint BRC and CBS Seminar with Jeremy Hall from Cardiff University.
| A Clinical and Biomedical Sciences seminar | |
|---|---|
| Date | 8 May 2024 |
| Time | 15:00 to 6:30 |
| Place | Room 3.06 or via Zoom |
| Organizer | Nicholas Clifton, Harry Green and Gareth Hawkes |
Event details
Abstract
Ever since it was first described by Bleuler, schizophrenia has been considered to potentially be a condition defined by altered associative learning. Recent years have seen major advances in psychiatric genetics which have highlighted genes involved in learning and plasticity, as well as immune pathways, as being implicated in psychotic conditions such as schizophrenia. In this talk I will review evidence of altered association formation in schizophrenia and examine the effect of specific genes, especially voltage gated calcium channels, on plasticity and risk for psychosis. Finally, I will present recent data suggesting unexpected convergence between different pathways of risk for schizophrenia.
We are pleased to invite you to this joint BRC and CBS Seminar with Jeremy Hall, from Cardiff University. This will be a hybrid seminar with the speaker presenting live in-person in South Cloisters room 3.06 on the St Luke’s Campus. There is also the option join virtually – a Zoom joining link and full details to sign in can be found below.
A drinks reception with alcoholic drinks and nibbles will also be provided at the seminar. Please feel free to forward this invitation to colleagues and networks.
Event: Wednesday 5th May 3:00- 4:30pm St Luke's Campus, South Cloisters 3.06
Title: Investigating the impact of schizophrenia risk genes on learning and plasticity
Bio: Jeremy is the Hodge Professor of Psychiatry and Neuroscience at Cardiff University. His overarching interest is in the role of genetic and environmental risk factors in the development of serious mental illness. In his work he employs a translational approach spanning human and laboratory studies. He is particularly interested in how identified genetic risk factors affect learning processes in the brain; abnormalities in which underlie key symptoms.Overall he believes that understanding how genetic risk factors influence the brain and how these responses are modulated by environmental stimuli is crucial to the development of new treatments for psychiatric symptoms. In addition to his research work he is also clinically active and conduct clinics in neuropsychiatry. In addition to his pre-clinical work he also conducts clinical work and research in the fields of adult neurodevelopmental disorders and early psychosis.
